$123.96▴ 0.02%
End-of-day close · 2026-07-14
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Nuvalent, Inc. - Class A Common Stock's earnings-quality signal is not available yet.
Key numbers
Recent news
Halper Sadeh LLC is Investigating Whether LCII, NUVL, DAN, TMHC are Obtaining Fair Deals for their Shareholders
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning The Merger—PFLC, NUVL, CCRN, and BGMS
Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion